- Home
- CARE vs ATAI Comparison
CARE vs ATAI Comparison
Compare CARE & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CARE
- ATAI
- Stock Information
- Founded
- CARE 1974
- ATAI 2018
- Country
- CARE United States
- ATAI Germany
- Employees
- CARE N/A
- ATAI N/A
- Industry
- CARE Major Banks
- ATAI Biotechnology: Pharmaceutical Preparations
- Sector
- CARE Finance
- ATAI Health Care
- Exchange
- CARE Nasdaq
- ATAI Nasdaq
- Market Cap
- CARE 330.3M
- ATAI 282.6M
- IPO Year
- CARE N/A
- ATAI 2021
- Fundamental
- Price
- CARE $16.52
- ATAI $2.41
- Analyst Decision
- CARE Buy
- ATAI Strong Buy
- Analyst Count
- CARE 2
- ATAI 3
- Target Price
- CARE $21.50
- ATAI $10.50
- AVG Volume (30 Days)
- CARE 74.0K
- ATAI 2.9M
- Earning Date
- CARE 07-24-2025
- ATAI 05-14-2025
- Dividend Yield
- CARE N/A
- ATAI N/A
- EPS Growth
- CARE 111.89
- ATAI N/A
- EPS
- CARE 1.20
- ATAI N/A
- Revenue
- CARE $146,558,000.00
- ATAI $1,863,000.00
- Revenue This Year
- CARE $10.63
- ATAI $554.22
- Revenue Next Year
- CARE $14.34
- ATAI N/A
- P/E Ratio
- CARE $13.79
- ATAI N/A
- Revenue Growth
- CARE 18.52
- ATAI 572.56
- 52 Week Low
- CARE $11.96
- ATAI $1.03
- 52 Week High
- CARE $20.40
- ATAI $2.64
- Technical
- Relative Strength Index (RSI)
- CARE 61.62
- ATAI 69.52
- Support Level
- CARE $16.33
- ATAI $2.18
- Resistance Level
- CARE $16.79
- ATAI $2.56
- Average True Range (ATR)
- CARE 0.32
- ATAI 0.22
- MACD
- CARE 0.03
- ATAI 0.03
- Stochastic Oscillator
- CARE 80.00
- ATAI 76.53
About CARE Carter Bankshares Inc.
Carter Bankshares Inc is a bank holding company that conducts its business solely through the bank. The Bank earns revenue from interest on loans and securities and fees charged for financial services provided to customers. It offers a full range of deposit services including Lifetime Free Checking, interest checking accounts, savings accounts, retirement accounts and other deposit accounts of various types, ranging from money market accounts to longer-term CDs. The Bank offers a full range of commercial and consumer loans. The Bank also originates and holds fixed and variable-rate mortgage loans and offers home equity lines of credit to its customers.
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.